Asia-Pacific Spinal Muscular Atrophy Medicine Market Report 2018

Name: Asia-Pacific Spinal Muscular Atrophy Medicine Market Report 2018
Brand: QYResearch
SKU: AA5ABAC8756QEN
Price: 4000 USD
Availability: InStock

February 2018 | 117 pages | ID: AA5ABAC8756QEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

Abstracts
Contents

In this report, the Asia-Pacific Spinal Muscular Atrophy Medicine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Spinal Muscular Atrophy Medicine for these regions, from 2013 to 2025 (forecast), including

China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia

Asia-Pacific Spinal Muscular Atrophy Medicine market competition by top manufacturers/players, with Spinal Muscular Atrophy Medicine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Astellas Pharma Inc.
AveXis, Inc.
Bioblast Pharma Ltd.
Cytokinetics, Inc. 24
F. Hoffmann-La Roche Ltd.
Genethon
Genzyme Corporation
GMP-Orphan SAS
Ionis Pharmaceuticals, Inc.
Longevity Biotech, Inc
Neurodyn Inc.
Neurotune AG
Novartis AG
Sarepta Therapeutics, Inc.
Voyager Therapeutics, Inc.
Vybion, Inc.
WAVE Life Sciences Ltd.

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into

LMI-070
ND-602
NT-1654
Nusinersen
NXD-30001
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Hospital
Clinic
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Asia-Pacific Spinal Muscular Atrophy Medicine Market Report 2018

1 SPINAL MUSCULAR ATROPHY MEDICINE OVERVIEW

1.1 Product Overview and Scope of Spinal Muscular Atrophy Medicine
1.2 Classification of Spinal Muscular Atrophy Medicine by Product Category
  1.2.1 Asia-Pacific Spinal Muscular Atrophy Medicine Market Size (Sales) Comparison by Types (2013-2025)
  1.2.2 Asia-Pacific Spinal Muscular Atrophy Medicine Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 LMI-070
  1.2.4 ND-602
  1.2.5 NT-1654
  1.2.6 Nusinersen
  1.2.7 NXD-30001
  1.2.8 Others
1.3 Asia-Pacific Spinal Muscular Atrophy Medicine Market by Application/End Users
  1.3.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales (Volume) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 Asia-Pacific Spinal Muscular Atrophy Medicine Market by Region
  1.4.1 Asia-Pacific Spinal Muscular Atrophy Medicine Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 China Status and Prospect (2013-2025)
  1.4.3 Japan Status and Prospect (2013-2025)
  1.4.4 South Korea Status and Prospect (2013-2025)
  1.4.5 Taiwan Status and Prospect (2013-2025)
  1.4.6 India Status and Prospect (2013-2025)
  1.4.7 Southeast Asia Status and Prospect (2013-2025)
  1.4.8 Australia Status and Prospect (2013-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Spinal Muscular Atrophy Medicine (2013-2025)
  1.5.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales and Growth Rate (2013-2025)
  1.5.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2025)

2 ASIA-PACIFIC SPINAL MUSCULAR ATROPHY MEDICINE COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Spinal Muscular Atrophy Medicine Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue and Share by Players/Suppliers (2013-2018)
2.2 Asia-Pacific Spinal Muscular Atrophy Medicine (Volume and Value) by Type
  2.2.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales and Market Share by Type (2013-2018)
  2.2.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue and Market Share by Type (2013-2018)
2.3 Asia-Pacific Spinal Muscular Atrophy Medicine (Volume) by Application
2.4 Asia-Pacific Spinal Muscular Atrophy Medicine (Volume and Value) by Region
  2.4.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales and Market Share by Region (2013-2018)
  2.4.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue and Market Share by Region (2013-2018)

3 CHINA SPINAL MUSCULAR ATROPHY MEDICINE (VOLUME, VALUE AND SALES PRICE)

3.1 China Spinal Muscular Atrophy Medicine Sales and Value (2013-2018)
  3.1.1 China Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018)
  3.1.2 China Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018)
  3.1.3 China Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018)
3.2 China Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type
3.3 China Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application

4 JAPAN SPINAL MUSCULAR ATROPHY MEDICINE (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Spinal Muscular Atrophy Medicine Sales and Value (2013-2018)
  4.1.1 Japan Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018)
  4.1.2 Japan Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018)
  4.1.3 Japan Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018)
4.2 Japan Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type
4.3 Japan Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application

5 SOUTH KOREA SPINAL MUSCULAR ATROPHY MEDICINE (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Spinal Muscular Atrophy Medicine Sales and Value (2013-2018)
  5.1.1 South Korea Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018)
  5.1.2 South Korea Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018)
  5.1.3 South Korea Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018)
5.2 South Korea Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type
5.3 South Korea Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application

6 TAIWAN SPINAL MUSCULAR ATROPHY MEDICINE (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Spinal Muscular Atrophy Medicine Sales and Value (2013-2018)
  6.1.1 Taiwan Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018)
  6.1.2 Taiwan Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018)
  6.1.3 Taiwan Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018)
6.2 Taiwan Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type
6.3 Taiwan Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application

7 INDIA SPINAL MUSCULAR ATROPHY MEDICINE (VOLUME, VALUE AND SALES PRICE)

7.1 India Spinal Muscular Atrophy Medicine Sales and Value (2013-2018)
  7.1.1 India Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018)
  7.1.2 India Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018)
  7.1.3 India Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018)
7.2 India Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type
7.3 India Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application

8 SOUTHEAST ASIA SPINAL MUSCULAR ATROPHY MEDICINE (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Spinal Muscular Atrophy Medicine Sales and Value (2013-2018)
  8.1.1 Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018)
  8.1.2 Southeast Asia Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018)
  8.1.3 Southeast Asia Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018)
8.2 Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type
8.3 Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application

9 AUSTRALIA SPINAL MUSCULAR ATROPHY MEDICINE (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Spinal Muscular Atrophy Medicine Sales and Value (2013-2018)
  9.1.1 Australia Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018)
  9.1.2 Australia Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018)
  9.1.3 Australia Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018)
9.2 Australia Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type
9.3 Australia Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application

10 ASIA-PACIFIC SPINAL MUSCULAR ATROPHY MEDICINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Astellas Pharma Inc.
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  10.1.4 Main Business/Business Overview
10.2 AveXis, Inc.
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 AveXis, Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  10.2.4 Main Business/Business Overview
10.3 Bioblast Pharma Ltd.
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  10.3.4 Main Business/Business Overview
10.4 Cytokinetics, Inc.
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  10.4.4 Main Business/Business Overview
10.5 F. Hoffmann-La Roche Ltd.
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  10.5.4 Main Business/Business Overview
10.6 Genethon
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Genethon Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  10.6.4 Main Business/Business Overview
10.7 Genzyme Corporation
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Genzyme Corporation Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  10.7.4 Main Business/Business Overview
10.8 GMP-Orphan SAS
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  10.8.4 Main Business/Business Overview
10.9 Ionis Pharmaceuticals, Inc.
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  10.9.4 Main Business/Business Overview
10.10 Longevity Biotech, Inc
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
  10.10.4 Main Business/Business Overview
10.11 Neurodyn Inc.
10.12 Neurotune AG
10.13 Novartis AG
10.14 Sarepta Therapeutics, Inc.
10.15 Voyager Therapeutics, Inc.
10.16 Vybion, Inc.
10.17 WAVE Life Sciences Ltd.

11 SPINAL MUSCULAR ATROPHY MEDICINE MANUFACTURING COST ANALYSIS

11.1 Spinal Muscular Atrophy Medicine Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Spinal Muscular Atrophy Medicine

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Spinal Muscular Atrophy Medicine Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Spinal Muscular Atrophy Medicine Major Manufacturers in 2017
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC SPINAL MUSCULAR ATROPHY MEDICINE MARKET FORECAST (2018-2025)

15.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume, Revenue and Price Forecast (2018-2025)
  15.1.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate Forecast (2018-2025)
  15.1.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue and Growth Rate Forecast (2018-2025)
  15.1.3 Asia-Pacific Spinal Muscular Atrophy Medicine Price and Trend Forecast (2018-2025)
15.2 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate Forecast by Region (2018-2025)
  15.2.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.3 China Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.4 Japan Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.5 South Korea Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.6 Taiwan Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.7 India Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.8 Southeast Asia Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.9 Australia Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025)
15.3 Asia-Pacific Spinal Muscular Atrophy Medicine Sales, Revenue and Price Forecast by Type (2018-2025)
  15.3.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Forecast by Type (2018-2025)
  15.3.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Forecast by Type (2018-2025)
  15.3.3 Asia-Pacific Spinal Muscular Atrophy Medicine Price Forecast by Type (2018-2025)
15.4 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Forecast by Application (2018-2025)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List of Tables and Figures

Figure Product Picture of Spinal Muscular Atrophy Medicine
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2025)
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (Product Category) in 2017
Figure LMI-070 Product Picture
Figure ND-602 Product Picture
Figure NT-1654 Product Picture
Figure Nusinersen Product Picture
Figure NXD-30001 Product Picture
Figure Others Product Picture
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales (K Pcs) by Application (2013-2025)
Figure Asia-Pacific Sales Market Share of Spinal Muscular Atrophy Medicine by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Market Size (Million USD) by Region (2013-2025)
Figure China Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure South Korea Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Taiwan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Australia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Market Major Players Product Sales Volume (K Pcs)(2013-2018)
Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Share by Players/Suppliers
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Market Major Players Product Revenue (Million USD) 2013-2018
Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Share by Players
Figure 2017 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Share by Players
Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales and Market Share by Type (2013-2018)
Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Share by Type (2013-2018)
Figure Sales Market Share of Spinal Muscular Atrophy Medicine by Type (2013-2018)
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Growth Rate by Type (2013-2018)
Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) and Market Share by Type (2013-2018)
Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Spinal Muscular Atrophy Medicine by Type (2013-2018)
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Growth Rate by Type (2013-2018)
Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Share by Region (2013-2018)
Figure Sales Market Share of Spinal Muscular Atrophy Medicine by Region (2013-2018)
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share by Region in 2017
Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) and Market Share by Region (2013-2018)
Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Spinal Muscular Atrophy Medicine by Region (2013-2018)
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Market Share by Region in 2017
Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Share (%) by Application (2013-2018)
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share by Application (2013-2018)
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share by Application (2013-2018)
Figure China Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018)
Table China Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018)
Table China Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018)
Figure China Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017
Table China Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Applications (2013-2018)
Table China Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018)
Figure China Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017
Figure Japan Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018)
Figure Japan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017
Table Japan Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Applications (2013-2018)
Table Japan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018)
Figure Japan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017
Figure South Korea Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure South Korea Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018)
Figure South Korea Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018)
Table South Korea Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018)
Table South Korea Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018)
Figure South Korea Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017
Table South Korea Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Applications (2013-2018)
Table South Korea Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018)
Figure South Korea Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017
Figure Taiwan Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure Taiwan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Taiwan Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018)
Table Taiwan Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018)
Table Taiwan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018)
Figure Taiwan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017
Table Taiwan Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Applications (2013-2018)
Table Taiwan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018)
Figure Taiwan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017
Figure India Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018)
Table India Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018)
Table India Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018)
Figure India Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017
Table India Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Application (2013-2018)
Table India Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018)
Figure India Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017
Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017
Table Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Applications (2013-2018)
Table Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017
Figure Australia Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure Australia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Australia Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018)
Table Australia Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018)
Table Australia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018)
Figure Australia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017
Table Australia Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Applications (2013-2018)
Table Australia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018)
Figure Australia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017
Table Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Basic Information List
Table Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018)
Figure Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018)
Table AveXis, Inc. Spinal Muscular Atrophy Medicine Basic Information List
Table AveXis, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AveXis, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure AveXis, Inc. Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018)
Figure AveXis, Inc. Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018)
Table Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Basic Information List
Table Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018)
Figure Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018)
Table Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Basic Information List
Table Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018)
Figure Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018)
Table F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Basic Information List
Table F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018)
Table Genethon Spinal Muscular Atrophy Medicine Basic Information List
Table Genethon Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genethon Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure Genethon Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018)
Figure Genethon Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018)
Table Genzyme Corporation Spinal Muscular Atrophy Medicine Basic Information List
Table Genzyme Corporation Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genzyme Corporation Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure Genzyme Corporation Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018)
Figure Genzyme Corporation Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018)
Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Basic Information List
Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018)
Figure GMP-Orphan SAS Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018)
Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Basic Information List
Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018)
Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018)
Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Basic Information List
Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
Figure Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018)
Figure Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018)
Table Neurodyn Inc. Spinal Muscular Atrophy Medicine Basic Information List
Table Neurotune AG Spinal Muscular Atrophy Medicine Basic Information List
Table Novartis AG Spinal Muscular Atrophy Medicine Basic Information List
Table Sarepta Therapeutics, Inc. Spinal Muscular Atrophy Medicine Basic Information List
Table Voyager Therapeutics, Inc. Spinal Muscular Atrophy Medicine Basic Information List
Table Vybion, Inc. Spinal Muscular Atrophy Medicine Basic Information List
Table WAVE Life Sciences Ltd. Spinal Muscular Atrophy Medicine Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Pcs) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Spinal Muscular Atrophy Medicine
Figure Manufacturing Process Analysis of Spinal Muscular Atrophy Medicine
Figure Spinal Muscular Atrophy Medicine Industrial Chain Analysis
Table Raw Materials Sources of Spinal Muscular Atrophy Medicine Major Manufacturers in 2017
Table Major Buyers of Spinal Muscular Atrophy Medicine
Table Distributors/Traders List
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) Forecast by Region (2018-2025)
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume Market Share Forecast by Region in 2025
Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) Forecast by Region (2018-2025)
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Market Share Forecast by Region in 2025
Figure China Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure South Korea Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure South Korea Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Taiwan Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Taiwan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Australia Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Australia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales (K Pcs) Forecast by Type (2018-2025)
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) Forecast by Type (2018-2025)
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Spinal Muscular Atrophy Medicine Price (USD/Pcs) Forecast by Type (2018-2025)
Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales (K Pcs) Forecast by Application (2018-2025)
Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Asia-Pacific Spinal Muscular Atrophy Medicine Market Report 2018

More Publications

Need Help?

Ask a Question

Market Reports